Modulating CLE Polypeptides to Control Vascular Tissue Growth

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current understanding of plant growth, particularly in vascular tissue, is limited, and there is a need for genetic elements that can be manipulated to alter plant growth and structure for increased biomass production, such as for biofuels and paper industries.

Innovation Solution

Modulation of CLE41 and CLE42 polypeptides and their receptors, like PXY, to influence cell division and differentiation in vascular tissue, achieved through genetic manipulation to increase or decrease the number of procambial and cambial cells, thereby altering secondary growth and vascular tissue organization.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If current understanding of plant growth is used, then conventional breeding and management practices are applied, but biomass production remains limited due to insufficient control over vascular tissue development

Engineering Contradiction:
Improvebiomass productionVSAvoidunderstanding of plant growth
Core Design Contradiction:
ProductivityVSLoss of information

Solution Approach 1:

The invention changes the biological parameter of CLE polypeptide expression levels to control vascular tissue development. By modulating the amount of CLE41 and CLE42 polypeptides expressed in the plant, the invention directly alters cell division and differentiation processes in procambial and cambial cells, thereby increasing biomass production without being constrained by conventional breeding limitations

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention uses CLE polypeptides as intermediary signaling molecules to mediate communication between cells in the vascular tissue. These polypeptides act as messengers that trigger downstream signaling pathways, ultimately controlling gene expression changes that regulate cell proliferation and differentiation, thus enabling precise control over vascular tissue development and biomass accumulation

Inventive Principle:
Principle #24Intermediary (Mediator)

2Shape

If genetic manipulation of CLE polypeptides is performed, then vascular tissue organization is improved and radial thickness of xylem increases, but the complexity of the genetic modification process increases

Engineering Contradiction:
Improveradial thickness of xylemVSAvoidgenetic manipulation process
Core Design Contradiction:
ShapeVSDevice complexity

Solution Approach 1:

The invention applies local quality by specifically targeting vascular tissue (procambial and cambial cells) for modification rather than the entire plant. By using promoters that are specific to vascular tissue, the CLE polypeptide expression is localized to the relevant cell types, achieving precise control over xylem radial thickness while minimizing off-target effects and simplifying the genetic manipulation strategy

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The invention utilizes the universal CLE signaling pathway that is conserved across different plant species. The CLE41 and CLE42 polypeptides interact with conserved receptor kinases (such as PXY/TTK) to regulate vascular development, allowing the same genetic modification approach to be applied universally across multiple plant species for biomass production improvement

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS11193140B2Method for the alteration of plants using CLE polypeptides/peptides
Publication Date: 2021.12.07 STORA ENSO OYJ
  • US11193140B2 patent drawing
  • US11193140B2 patent drawing
  • US11193140B2 patent drawing

AI summary

The present invention relates to altering the biomass and/or structure of a plant, in order to maximise its potential as a source of feedstock or increase its potential as a feedstock for the paper industry. CLE41 and/or CLE42 are used to manipulate growth and structure of the vascular tissue of the plant. The present invention also provides plants in which the levels of CLE41 and/or CLE42 are increased compared to those of a native plant grown under identical conditions, and parts of such plants. Also provided are methods for using such plants or plant parts in the production of plant derived products such as paper or biofuels.